TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01612117 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01612117 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04380753 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03773991 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05798806 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT00870974 — Predictive Biomarker (PRD): GRM5 mRNA
Genes: GRM5; GPRC1E; MGLUR5
Study NCT04328012 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02473120 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01765946 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT01765946 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01765946 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT01765946 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT01765946 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study NCT01765946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00422890 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04231565 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02541201 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04210115 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03850301 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT01743170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02770118 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT02770118 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04487730 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04098744 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00543725 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04359680 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04960943 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04960943 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04960943 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01371526 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00968630 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01768338 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT04379986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03771690 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT04196920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05450120 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04117087 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03851185 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01637597 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06238037 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00568282 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT01663142 — Predictive Biomarker (PRD): IRGM mRNA
Genes: IRGM; IFI1; IRGM1; LRG47
Study NCT03704922 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04368468 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04368468 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04368468 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04368468 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT00734487 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02533128 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02533128 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT01830673 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03401580 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04179656 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03615326 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02297737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04467489 — Predictive Biomarker (PRD): CFLAR mRNA
Genes: CFLAR; CASH; CASP8AP1; CLARP; MRIT
Study NCT01779206 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03125577 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03125577 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03125577 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03125577 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03125577 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT01585493 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04581629 — Predictive Biomarker (PRD): ADH1A mRNA
Genes: ADH1A; ADH1
Study NCT02895412 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00330811 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00406731 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03164174 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT03164174 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT02739880 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00815204 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00815204 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT00753597 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT05367557 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00707460 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00202852 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02273869 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05060796 — Predictive Biomarker (PRD): CXCR5 mRNA
Genes: CXCR5; BLR1; MDR15
Study NCT05060796 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05060796 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04003389 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04003389 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03586453 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01639456 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01639456 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01340118 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00392548 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00392548 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02725606 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01937468 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05594433 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02194556 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00544687 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00544687 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04918914 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT01509456 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00557739 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00557739 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04054661 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT03029858 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03029858 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03029858 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04530396 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01355510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03769116 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03076164 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00274794 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01357746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02228811 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT02303769 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02162238 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00411086 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03902483 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00353327 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02719574 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT00589732 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01425229 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT01425229 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01425229 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01425229 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study NCT01425229 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00266500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02121470 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02121470 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04086602 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT04152148 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04152148 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00989443 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03434418 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03434418 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04404283 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03556384 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT01700569 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00579488 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00579488 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00754559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00754559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04107285 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02511769 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01633385 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01378273 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03729141 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03375164 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04052555 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04052555 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01946412 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01217411 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02302833 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02670928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04087655 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02197364 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT05382988 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00154713 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02113813 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02113813 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02113813 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04656028 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT00745381 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study NCT01646801 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT03179709 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT03697486 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT04137419 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01000428 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01000428 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01884961 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01884961 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02452177 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT02452177 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03227575 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02207101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05943990 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01263314 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03859856 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00626665 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00626665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01245205 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00703859 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03714009 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03714009 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03714009 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01619163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01084759 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00087269 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03881878 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03000634 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study NCT03412552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00324545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03607812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01951729 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04298112 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00159874 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03692026 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01514279 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04396860 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03381651 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03760081 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT03760081 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01771367 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04281576 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01051882 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02221297 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT03852615 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03389100 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04739345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04739345 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03162341 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02708368 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02708368 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT02708368 — Predictive Biomarker (PRD): BMP2 mRNA
Genes: BMP2; BMP2A
Study NCT02708368 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT03678727 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00544726 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02227472 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03082976 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03082976 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03242304 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03242304 — Safety Biomarker (SAF): BDNF
Study NCT01584297 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT01584297 — Predictive Biomarker (PRD): FOXL2 mRNA
Genes: FOXL2
Study NCT00086463 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00880503 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03288259 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02155062 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04082572 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03798587 — Predictive Biomarker (PRD): SENP1 mRNA
Genes: SENP1
Study NCT03798587 — Predictive Biomarker (PRD): ZEB1 mRNA
Genes: ZEB1; AREB6; TCF8
Study NCT04780945 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04780945 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04780945 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04780945 — Predictive Biomarker (PRD): RAD51 mRNA
Genes: RAD51; RAD51A; RECA
Study NCT04780945 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT02693236 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT00554463 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01565434 — Predictive Biomarker (PRD): CR1 mRNA
Genes: CR1; C3BR
Study NCT02016599 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00792155 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT00792155 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00420056 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT03255265 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01340963 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00233961 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02328391 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02328391 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04700436 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06691607 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04003181 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT02059122 — Predictive Biomarker (PRD): IVNS1ABP mRNA
Genes: IVNS1ABP; ARA3; FLARA3; KIAA0850; KLHL39; NS1; NS1BP; HSPC068
Study NCT00908141 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01252485 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT02914483 — Predictive Biomarker (PRD): ANKS4B mRNA
Genes: ANKS4B; HARP
Study NCT01679665 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00558480 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03515018 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00506311 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01871207 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01871207 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00232505 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01273675 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01273675 — Safety Biomarker (SAF): Urinary microalbumin
Study NCT01273675 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02778945 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT01217047 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03379493 — Predictive Biomarker (PRD): DCLRE1C mRNA
Genes: DCLRE1C; ARTEMIS; ASCID; SCIDA; SNM1C
Study NCT03379493 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19